Cell Source, Inc.
CLCS
$0.27
-$0.03-10.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 470.80K | 373.70K | 781.90K | 507.00K | 480.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 831.60K | 1.19M | 1.14M | 866.40K | 995.40K |
| Operating Income | -831.60K | -1.19M | -1.14M | -866.40K | -995.40K |
| Income Before Tax | -1.42M | -1.49M | -1.28M | -1.05M | -1.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.42M | -1.49M | -1.28M | -1.05M | -1.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.42M | -1.49M | -1.28M | -1.05M | -1.34M |
| EBIT | -831.60K | -1.19M | -1.14M | -866.40K | -995.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| EPS Diluted | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 42.43M | 41.02M | 40.51M | 38.67M | 38.19M |
| Average Diluted Shares Outstanding | 42.43M | 41.02M | 40.51M | 38.67M | 38.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |